Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

YILMAZ Y., Ozturk O., Alandab Y., Senates E., ÇOLAK Y., Doganay H. L., ...More

DIGESTIVE AND LIVER DISEASE, vol.45, no.1, pp.58-62, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 45 Issue: 1
  • Publication Date: 2013
  • Doi Number: 10.1016/j.dld.2012.08.017
  • Journal Name: DIGESTIVE AND LIVER DISEASE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.58-62
  • Keywords: Biomarker, Inflammation, Nonalcoholic fatty liver disease, Osteopontin, Portal inflammation, METABOLIC SYNDROME, HEPATOCELLULAR-CARCINOMA, STEATOHEPATITIS, ASSOCIATION, STEATOSIS, OBESITY, MARKER, EXPRESSION, FIBROSIS, HEDGEHOG
  • Recep Tayyip Erdoğan University Affiliated: No

Abstract

Background: Osteopontin is a secreted phosphorylated glycoprotein that is expressed by a variety of cell types and that mediates numerous and diverse biological functions.